Albumin conjugation comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-07-09. Numbers and descriptions here follow the published literature rather than marketing material.
CJC-1295 belongs to a class of synthetic peptides modeled on growth hormone releasing hormone, a forty-four amino acid signal produced by the hypothalamus. The compound is built from the first twenty-nine residues of the natural sequence, with four substitutions introduced at positions 2, 8, 15 and 27. These changes were designed to slow enzymatic breakdown while preserving receptor activation. The result is a peptide that is shorter than native GHRH and considerably more resistant to ordinary clearance pathways in circulation.
Two related forms appear under the CJC-1295 name. The simpler analogue, commonly written as modified GRF(1-29), carries the four substitutions but no additional conjugation. The second form attaches a maleimidopropionic acid linker to a lysine residue, a modification frequently called the drug affinity complex. That linker reacts with the free thiol on serum albumin to form a covalent bond. Because albumin has a long residence time in blood, the conjugated peptide stays in circulation far longer than the unconjugated analogue.
Receptor level activity follows the canonical GHRH pathway. The peptide binds the GHRH receptor, a class B G protein coupled receptor on somatotroph cells of the anterior pituitary. Binding raises intracellular cyclic AMP, which promotes calcium entry and the release of growth hormone into the bloodstream. Because the molecule acts at the same receptor as the endogenous hormone, its effect is superimposed on the natural pulsatile rhythm rather than replacing it. Whether sustained receptor occupation leads to desensitization is not fully settled.
CJC-1295 belongs to a family of synthetic peptides modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound is built from the first twenty-nine amino acids of the natural human sequence, a fragment that retains full receptor binding capacity. Native growth hormone-releasing hormone is degraded quickly in circulation, so the fragment alone has limited practical value. Early work therefore focused on chemical modifications that preserve receptor binding while slowing enzymatic breakdown. The result is a molecule described in the literature as a long-acting analog of the natural hormone.
Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.
| Property | Value | Notes |
|---|---|---|
| Peptide class | Synthetic GHRH analogue | Built on a 29 residue sequence |
| Primary target | GHRH receptor (GHRHR) | Class B G protein coupled receptor |
| Unconjugated half life | Minutes | Limited by protease degradation |
| Key modification | Four residue substitutions | Positions 2, 8, 15 and 27 |
| Common synonym | Modified GRF(1-29) | Usually denotes the form without DAC |
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, built on the 29-amino-acid GHRH(1-29) fragment. Four substitutions distinguish it from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes reduce enzymatic cleavage and extend the peptide's persistence in circulation. The compound is discussed in two forms, one carrying a drug affinity complex and one without it.
The drug affinity complex is a maleimidopropionic acid group attached to a lysine side chain. It reacts with the free thiol of cysteine-34 on circulating albumin, forming a covalent bond. This conjugation keeps the peptide in the bloodstream and shields it from rapid renal filtration and proteolysis. Reported circulation half-lives for the albumin-bound form fall in the range of roughly six to nine days in early human studies.
The distinguishing feature of the DAC form is a maleimide-containing group that reacts with the free thiol of cysteine-34 on human serum albumin. This reaction forms a covalent bond without enzymatic assistance, and it takes place after the peptide enters the bloodstream. Because albumin is abundant and long-lived, the attached peptide is carried through circulation far longer than an unmodified fragment would survive. The chemistry is a deliberate pharmacokinetic strategy rather than a change to receptor activity.
Enzymatic protection is a separate mechanism from plasma protein binding. The four substitutions in the backbone reduce recognition by dipeptidyl peptidase IV, which normally cleaves the natural hormone within minutes. Without the reactive group, this resistance still yields only a short window of activity, generally reported in the range of tens of minutes. With it, reported half-lives in early human work extended to several days. The size of that gap is the main practical distinction between the two materials.
Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.
The albumin-binding version stays in circulation for days, because covalent attachment to serum albumin shields the peptide from rapid filtration and degradation. Reported half-lives for this form fall in the range of several days. The version without the linker is cleared in minutes, with estimates often near thirty minutes in animal work. These figures come from small studies and vary with assay method, species, and route, so they are best read as approximate rather than fixed constants.
Absorbance Units Full Scale (AUFS) or Absorption Units Full Scale is a unit of absorbance intensity that denotes the output of a spectrophotometer. The acronym AUFS can also be written out as Absorbance Units per Full Scale Deflection.
Helton is one of only two Hall-of-Famers to have played for the Rockies (the other being Larry Walker, who was in the class of 2020), and is the only MLB Hall-of-Famer to have played his entire career for the Rockies.
Some residents warned that, if the situation continued for another week or two, it could lead to a humanitarian crisis, and also expressed concern that the districts might fall to Pakistani forces. Since the closure of roads, Taliban have been airlifting essential supplies to effected areas. Locals in Nuristan also said that the road between Kunar and Nuristan had been closed, and that Pakistani soldiers targeted anyone travelling along the route. Residents of Kunar and Nuristan state that while artillery attacks had occurred in the area for years, road closures and airstrikes had been relatively rare in the past. Meanwhile, an Afghan media outlet, citing a Pakistani official, reported that Pakistani security forces had taken control of several strategic border posts. The official said the positions had been secured because of their tactical importance and elevation, and stated that Pakistan's aim was not to seize Afghan territory but to prevent cross-border infiltration and protect vulnerable areas inside Pakistan. Enayatullah Toofan, a member of Taliban's High Council for Armed Forces Coordination, states that Pakistani forces have occupied parts of Paktika province and issued Pakistani identity cards to the residents there. According to him, Pakistan wants to open girls schools in those areas. However, Enayatullah Khwarizmi, a spokesperson for the Afghan Ministry of Defense, said that all areas on the Afghan side of the border remained under Afghan control and that the Afghan armed forces were committed to defending every inch of the country's territory.
Sources: en.wikipedia.org
The Mark V initially used a single power source for the flashlight, sprinting, and oxygen supply; in Half-Life 2: Episode Two the flashlight was given a separate power source to improve gameplay. The symbol on Gordon's HEV suit is the lowercase Greek letter Lambda, λ. This symbol is used by scientists to denote the decay constant of radioactive elements (related to the half-life of an element). As well as appearing on Gordon's suit, the symbol replaces the letter "a" in the game title (Hλlf-Life) and is the name of the complex in the Black Mesa Research Facility where teleportation experiments are conducted in the first game. The Lambda symbol is also seen in Half-Life 2 as a marking of the human resistance, seen close to hidden supplies and on the armbands of better equipped resistance fighters.
Synthetic biology is an interdisciplinary field that draws from and is inspired by many different scientific disciplines, not one single field or technique. Synthetic biologists all have the same underlying objective of designing and producing new forms of life, despite the fact that they may employ various methodologies, techniques, and research instruments. Any evaluation of synthetic biology, whether it examines ethical, legal, or safety considerations, must take into account the fact that while some questions, risks, and issues are unique to each technique, in other circumstances, synthetic biology as a whole must be taken into consideration.
=== Forced disappearances === Since the start of the civil war in 2011, more than 100,000 people have been detained, forcibly disappeared or went missing in Syria as of 2019. At least 90,000 of them are thought to have been detained or forcibly disappeared in Syria's state prisons. Other reports estimate that more than 128,000 civilians have been kidnapped or forcibly disappeared by the regime forces by 2019. Amnesty International stated in a 2019 press release: "Until today, the Syrian government has failed to disclose the fate, names and location of people arbitrarily detained and disappeared by Syrian security forces. Some families were notified about the death of their relatives in detention, or were eventually able to find out that their loved one died in custody. Those who receive a death certificate – the only piece of "evidence" provided – are legally bound to then register the person's death in civil records, in order to obtain an official death certificate."Between 2011 and 2015, more than 17,700 civilians captured under regime prisons were summarily executed. Between March 2011 and March 2023, an estimated 154,000 civilians have been forcibly disappeared, abducted or subject to arbitrary detentions in Syria; with over 135,000 individuals being tortured, imprisoned or dead in government detention centres as of 2023. In June 2023, UN General Assembly voted in favour of establishing an independent body to investigate the whereabouts hundreds of thousands of missing civilians who have been forcibly disappeared, killed or languishing in Syrian government prisons.
Sources: en.wikipedia.org
The names are often used interchangeably in casual writing, but they are not strictly identical. Modified GRF(1-29) refers to the unconjugated analogue carrying only the four substitutions. The version sold as CJC-1295 with DAC includes the albumin binding linker and clears much more slowly.
DAC stands for drug affinity complex, a term describing the maleimidopropionic acid linker. This group forms a covalent bond with the cysteine residue on serum albumin after administration. The resulting adduct is what extends the circulating half life from minutes to days.
No. It is entirely synthetic and does not correspond to any known endogenous peptide. The design starts from human growth hormone releasing hormone and introduces deliberate substitutions. Any biological effect comes from mimicking the natural hormone at its receptor.
The two share the same 29-amino-acid backbone. CJC-1295 carries an additional albumin-binding moiety that markedly extends its residence time in circulation, while the form without that moiety clears faster. Literature sometimes applies the name loosely to either variant.